Efficacy of everolimus on top to centre specific standard immunosuppressive regimen in lung transplant recipients

Registry ID

EUCTR2011-001539-21

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Novartis Pharma GmbH

Start date

2011-09-06

Completion date

2017-01-05

Last update

2026-08-16

Conditions

• lung transplantation

Summary

To demonstrate that an everolimus-based, quadruple immunosuppressive regimen has superior efficacy compared with a CNI-based triple immunosuppressive regimen on renal function as measured by cGFR according to CKD EPI at 12 months after randomization in lung transplant recipients.

Locations

• , , Germany

Related clinical trials

• Effect of epidural anesthesia on intraoperative and outcome parameters after lung transplantations

View on source registry